BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29728986)

  • 41. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.
    Rocca AS; Brubaker PL
    Endocrinology; 1999 Apr; 140(4):1687-94. PubMed ID: 10098504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic intestinal electrical stimulation improves glucose intolerance and insulin resistance in diet-induced obesity rats.
    Li S; Zhu W; Zhang S; Chen JDZ
    Obesity (Silver Spring); 2017 Jun; 25(6):1061-1068. PubMed ID: 28437585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
    Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
    Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
    Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
    J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nateglinide stimulates glucagon-like peptide-1 release by human intestinal L cells via a K(ATP) channel-independent mechanism.
    Kitahara Y; Miura K; Yasuda R; Kawanabe H; Ogawa S; Eto Y
    Biol Pharm Bull; 2011; 34(5):671-6. PubMed ID: 21532155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
    Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
    Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
    Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
    Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic Electrical Stimulation at Acupoints Reduces Body Weight and Improves Blood Glucose in Obese Rats via Autonomic Pathway.
    Liu J; Jin H; Foreman RD; Lei Y; Xu X; Li S; Yin J; Chen JD
    Obes Surg; 2015 Jul; 25(7):1209-16. PubMed ID: 25491914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
    Liu L; Wang F; Lu H; Ren X; Zou J
    Islets; 2014; 6(4):e962386. PubMed ID: 25437377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.
    Chae SY; Jin CH; Shin HJ; Youn YS; Lee S; Lee KC
    Bioconjug Chem; 2008 Jan; 19(1):334-41. PubMed ID: 18078308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats.
    Stygar D; Sawczyn T; Skrzep-Poloczek B; Owczarek AJ; Matysiak N; Michalski M; Mielańczyk Ł; Bażanów B; Ziora P; Choręza P; Doleżych B; Karcz KW
    Obes Surg; 2018 Mar; 28(3):748-759. PubMed ID: 28840471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Constitutive increase in active GLP-1 levels by the DPP4 inhibitor ASP4000 on a new meal tolerance test in Zucker fatty rats.
    Tanaka-Amino K; Hatakeyama Y; Takakura S; Mutoh S
    Pharmacol Res; 2009 Oct; 60(4):264-9. PubMed ID: 19520592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1).
    Bala M; Martin J; Kopp A; Hanses F; Buechler C; Schäffler A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2493-501. PubMed ID: 21677044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intestinal electric stimulation accelerates whole gut transit and promotes fat excrement in conscious rats.
    Sun Y; Chen JD
    Int J Obes (Lond); 2009 Aug; 33(8):817-23. PubMed ID: 19546870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased secretion of insulin and proliferation of islet β-cells in rats with mesenteric lymph duct ligation.
    Nagino K; Yokozawa J; Sasaki Y; Matsuda A; Takeda H; Kawata S
    Biochem Biophys Res Commun; 2012 Aug; 425(2):266-72. PubMed ID: 22842578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.